ECP, Second Drainage Device Effective in Refractory Glaucoma

This article originally appeared here.
Share this content:
ECP, Second Drainage Device Effective in Refractory Glaucoma
ECP, Second Drainage Device Effective in Refractory Glaucoma

THURSDAY, Sept. 1, 2016 (HealthDay News) -- For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are effective as second surgeries, according to a study published online Aug. 28 in Clinical & Experimental Ophthalmology.

Yohko Murakami, M.D., from the University of California San Francisco, and colleagues conducted a nonrandomized retrospective chart review of patients with refractory glaucoma following a failed initial tube shunt. Patients underwent ECP (25 eyes) or GDD-2 with Baerveldt Glaucoma Implant (48 eyes) as a second surgery.

The researchers found that both ECP and GDD-2 correlated with significant reductions in intraocular pressure and number of antiglaucoma medications. At six and 12 months there were no significant differences in postoperative intraocular pressure or antiglaucoma medications between the groups. There were no between-group differences in survival outcomes.

"Both ECP and GDD-2 are both effective as second surgeries for refractory glaucoma that has failed a prior aqueous shunt," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

60 Percent of Adults Report Adverse Childhood Experiences

>60 Percent of Adults Report Adverse Childhood Experiences

Higher ACE exposures for black, Hispanic, multiracial individuals, those with below high school education

Few Yogurt Products Qualify As Low-Sugar

Few Yogurt Products Qualify As Low-Sugar

Only two of 101 children's yogurt and fromage frais products had ≤5 g sugar/100 g of product

Allopurinol Dose Escalation for Gout Doesn't Improve Mortality

Allopurinol Dose Escalation for Gout Doesn't Improve Mortality

Linked to small increase in mortality; at 2 years, 31 percent of dose escalators achieved serum urate goal

is free, fast, and customized just for you!




Already a member?

Sign In Now »